Expression of extracellular calcium-sensing receptor in peripheral blood monocytes in patients with arteriosclerosis obliterans, diabetes mellitus type 2 complicated with macroangiopathy in the context of the selected proinflammatory factors

Diabetologia Doswiadczalna i Kliniczna

Volumn 7, Issue 5, 2007, Pages 235-239

  Małecki, Rafał ^a   Adamiec, Rajmund ^a   Jakobsche, Urszula ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Arteriosclerosis obliterans; Calcium sensing receptor; Cytokines; Diabetic macroangiopathy

Indexed keywords

CALCIUM SENSING RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASCULAR DISEASE;

EID: 39449117806     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Brown EM, Gamba G, Riccardi D. et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580.
2. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297.
3. Yamaguchi T, Olozak I, Chattopadhyay N. et al. Expression of extracellular calcium (Ca2+o)-sensing receptor in human peripheral blood monocytes. Biochem Biophys Res Commun 1998; 246: 501-506.
4. Olszak IT, Poznansky MC, Evans RH. et al. Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest 2000; 105: 1299-1305.
5. Bornefalk E, Ljunghall S, Lindh E, Bengsten O, Johansson A, Ljunggren O. Regulation of interleukin-6 secretion from mononuclear blood cells by extracellular calcium. J Bone Miner Res 1997; 12: 228-233.
6. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: A clinical perspective. Endocrine Rev 2001; 22: 36-52.
7. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
8. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-2642.
9. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994; 93: 2106-2113.
10. van der Meer IM, de Maat MP, Bots ML. et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2002; 22: 838-842.
11. Martinovic I, Abegunewardene N, Seul M. et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 2005; 69: 1484-1489.
12. Hoff JA, Quinn L, Sevrukov A. et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 2003; 41: 1008-1012.